Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE

Clinical trial NCT01702038 · WITHDRAWN

Trial details

NCT number

NCT01702038

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Status

WITHDRAWN

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-09-01

Enrollment

0

View on ClinicalTrials.gov